SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-12-000020
Filing Date
2012-03-23
Accepted
2012-03-23 16:58:58
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K a10k-123111.htm 10-K 1238949
2 SUBSIDIARIES ex_21.htm EX-21 3903
3 AUDITORS CONSENT ex_23-1.htm EX-23.1 4047
4 CEO CERTIFICATION ex_31-1.htm EX-31.1 21159
5 CFO CERTIFICATION ex_31-2.htm EX-31.2 21293
6 CEO AND CFO CERTIFICATION ex_32.htm EX-32 8286
  Complete submission text file 0000318306-12-000020.txt   4052287

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENTS accp-20111231.xml EX-101.INS 572246
8 XBRL TAXONOMY SCHEMA accp-20111231.xsd EX-101.SCH 15904
9 XBRL TAXONOMY CALCULATION LINKBASE accp-20111231_cal.xml EX-101.CAL 42381
10 XBRL TAXONOMY DEFINITION LINKBASE accp-20111231_def.xml EX-101.DEF 26776
11 XBRL TAXONOMY LABEL LINKBASE accp-20111231_lab.xml EX-101.LAB 213323
12 XBRL TAXONOMY PRESENTATION LINKBASE accp-20111231_pre.xml EX-101.PRE 113555
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 12712506
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences